30-day readmission and cost-analysis in patient with cirrhosis: a nationwide population-based data

30-day readmission and cost-analysis in patient with cirrhosis: a nationwide population-based data

Bibliographic Details
Main Authors:	Chirapongsathorn, S, Poovorawan, K, Soonthornworasiri, N, Pan-Ngum, W, Sanpajit, T, Phaosawasdi, K, Treeprasertsuk, S
Format:	Conference item
Language:	English
Published:	Elsevier 2017

Similar Items

Thirty-Day Readmission and Cost Analysis in Patients With Cirrhosis: A Nationwide Population-Based Data
by: Chirapongsathorn, S, et al.
Published: (2020)

Thirty-day readmission and cost-analysis in patients with cirrhosis: a nationwide population-based data
by: Chirapongsathorn, S, et al.
Published: (2019)

Thirty‐Day Readmission and Cost Analysis in Patients With Cirrhosis: A Nationwide Population‐Based Data
by: Sakkarin Chirapongsathorn, et al.
Published: (2020-03-01)

Health care burden and mortality of acute on chronic liver failure in Thailand: a nationwide population-based cohort study
by: Chirapongsathorn, S, et al.
Published: (2022)

Health care burden and mortality of acute on chronic liver failure in Thailand: a nationwide population-based cohort study
by: Sakkarin Chirapongsathorn, et al.
Published: (2022-02-01)

Characteristics and outcomes of cholangiocarcinoma by region in Thailand: A nationwide study
by: Chaiteerakij, R, et al.
Published: (2017)

The annual incidence, risk factors and outcomes of cholangiocarcinoma (CCA) among different regions in Thailand: A nationwide study
by: Roongruedee Chaiteerakij, et al.
Published: (2016)

A retrospective Thai nationwide study of the incidence of acute hepatitis A infection and the impact of chronic liver disease comorbidity on survival
by: Poovorawan, K, et al.
Published: (2018)

Factors affecting mortality and resource use for hospitalized patients with cirrhosis: A population-based study
by: Charatcharoenwitthaya, P, et al.
Published: (2017)

Different pattern of hepatic decompensation and mortality in hospitalized patients with alcoholic versus non-alcoholic liver cirrhosis: a population-based study
by: Charatcharoenwitthaya, P, et al.
Published: (2016)

The burden of cirrhosis and impact of universal coverage public health care system in Thailand: Nationwide study
by: Kittiyod Poovorawan, et al.
Published: (2015-11-01)

The incidence, presentation, outcomes, risk of mortality and economic data of drug-induced liver injury from a national database in Thailand: A population-base study
by: Sobhonslidsuk, A, et al.
Published: (2016)

Burden of liver abscess and survival risk score in Thailand: a population-based study
by: Poovorawan, K, et al.
Published: (2016)

The incidence, presentation, outcomes, risk of mortality and economic burden of drug-induced liver injury from a national database in Thailand
by: Sobhonslidsuk, A, et al.
Published: (2016)

Sex‐Based Differences in 30‐Day Readmissions After Cardiac Arrest: Analysis of the Nationwide Readmissions Database
by: Navjot Kaur Sobti, et al.
Published: (2022-09-01)

Outcomes and Predictors of 30-Day Readmissions for Hyperthyroidism: A Nationwide Study
by: Michael Salim, et al.
Published: (2021-12-01)

The incidence, etiologies, outcomes, and predictors of mortality of acute liver failure in Thailand: a population-base study
by: Kessarin Thanapirom, et al.
Published: (2019-01-01)

Characteristics of 30-day readmission in spontaneous pneumothorax in the United States: a nationwide retrospective study
by: Osama Mukhtar, et al.
Published: (2019-05-01)

Causes and Predictors of 30‐Day Readmission in Patients With Syncope/Collapse: A Nationwide Cohort Study
by: Amer N. Kadri, et al.
Published: (2018-09-01)

Associations Between Hospital Length of Stay, 30‐Day Readmission, and Costs in ST‐Segment–Elevation Myocardial Infarction After Primary Percutaneous Coronary Intervention: A Nationwide Readmissions Database Analysis
by: Sun‐Joo Jang, et al.
Published: (2020-06-01)

Unplanned 30-day readmissions in orthopaedic trauma
by: Metcalfe, D, et al.
Published: (2016)

“Weekend Effect” on 30-Day Readmissions among Stroke Survivors: An Analysis of the National Readmission Database
by: Bijan J. Khaksari, et al.
Published: (2019-06-01)

Decision support through risk cost estimation in 30-day hospital unplanned readmission.
by: Laura Arnal, et al.
Published: (2022-01-01)

Trends, Predictors, and Outcomes of 30‐Day Readmission With Heart Failure After Transcatheter Aortic Valve Replacement: Insights From the US Nationwide Readmission Database
by: Salman Zahid, et al.
Published: (2022-08-01)

Cost-utility analysis of non-contrast abbreviated magnetic resonance imaging for hepatocellular carcinoma surveillance in cirrhosis
by: Decharatanachart, P, et al.
Published: (2023)

Thirty‐Day Readmission After Infective Endocarditis: Analysis From a Nationwide Readmission Database
by: Yusuke Morita, et al.
Published: (2019-05-01)

Determining 30-day readmission risk for heart failure patients: the Readmission After Heart Failure scale
by: Chamberlain RS, et al.
Published: (2018-04-01)

Readmission in the 30 days after percutaneous coronary intervention
by: Shaik Subhani, et al.
Published: (2014-11-01)

Head and neck cancer readmission reduction (HANCARRE) project: Reducing 30‐day readmissions
by: Sara Yang, et al.
Published: (2022-06-01)

Causes and Predictors of 30‐Day Readmission in Patients With COVID‐19 and ST‐Segment–Elevation Myocardial Infarction in the United States: A Nationwide Readmission Database Analysis
by: Kunal N. Patel, et al.
Published: (2023-08-01)

Association of glucose variability at the last day of hospitalization with 30-day readmission in adults with diabetes
by: Guillermo E Umpierrez, et al.
Published: (2020-04-01)

Thirty-Day Readmission Rates after Takotsubo Syndrome with or without Malignancy: A Nationwide Readmissions Database Analysis
by: Sun-Joo Jang, et al.
Published: (2021-08-01)

Readmission After COPD Exacerbation Scale: determining 30-day readmission risk for COPD patients
by: Lau CSM, et al.
Published: (2017-06-01)

Serum cystatin C as a predictor of 90‐day mortality among patients admitted with complications of cirrhosis
by: Anuchit Suksamai, et al.
Published: (2021-05-01)

Examining 30-day COPD readmissions through the emergency department
by: Rezaee ME, et al.
Published: (2017-12-01)

Medication adherence as a predictor of 30-day hospital readmissions
by: Rosen OZ, et al.
Published: (2017-04-01)

One-year costs of medical admissions with and without a 30-day readmission and enhanced risk adjustment
by: Sarah Zheng, et al.
Published: (2019-03-01)

Association of Insurance Type With Inpatient Surgical 30-Day Readmissions, Emergency Department Visits/Observation Stays, and Costs
by: Michael A. Jacobs, MS, et al.
Published: (2023-03-01)

Regional differences in admissions and treatment outcomes for hepatocellular carcinoma patients in Thailand
by: Kitiyakara, T, et al.
Published: (2022)

Socio-demographic and -economic factors associated with 30-day readmission for conditions targeted by the hospital readmissions reduction program: a population-based study
by: Frances Murray, et al.
Published: (2021-10-01)